Gallus gallus isolate bGalGal1 chromosome 31, bGalGal1.mat.broiler.GRCg7b, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Gallus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028512.1.\nAssembly name: bGalGal1.mat.broiler.GRCg7b\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/01/19. The original whole-genome shotgun project has the\naccession JAENSK000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 22-JUL-2020\nAssembly Method :: TrioCanu v. 1.8; purge_dups v. 1.0.0;\n Scaff 10x v. 4.1.0; Bionano solve v.\n 3.2.1_04122018; Salsa2 HiC v. 2.2; Arrow\n polishing and gap filling v.\n SMRTLink7.0.1; Freebayes v. 1.3.1; gEVAL\n manual curation v. 2020-07-22; VGP trio\n assembly pipeline v. 1.6\nAssembly Name :: bGalGal1.mat.broiler.GRCg7b\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 102.01x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Gallus gallus Annotation Release 106\nAnnotation Version :: 106\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
coiled-coil domain-containing protein 81-like, transcript variant X1
coiled-coil domain-containing protein 81-like, transcript variant X3
coiled-coil domain-containing protein 81-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
coiled-coil domain-containing protein 81-like isoform X1
coiled-coil domain-containing protein 81-like isoform X2
uncharacterized protein LOC121107827 isoform X3
coiled-coil domain-containing protein 81-like, transcript variant X6
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
coiled-coil domain-containing protein 81-like, transcript variant X7
coiled-coil domain-containing protein 81-like, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized protein LOC121107826 isoform X1
coiled-coil domain-containing protein 81-like isoform X6
coiled-coil domain-containing protein 81-like isoform X4
coiled-coil domain-containing protein 81-like isoform X7
coiled-coil domain-containing protein 81-like, transcript variant X5
uncharacterized protein LOC121107826 isoform X3
uncharacterized protein LOC121107826 isoform X5
uncharacterized protein LOC121107800 isoform X1
uncharacterized LOC107049386, transcript variant X5
uncharacterized LOC107049386, transcript variant X3
uncharacterized LOC107049386, transcript variant X4
uncharacterized LOC107049386, transcript variant X6
uncharacterized LOC107049386, transcript variant X2
uncharacterized LOC107049386, transcript variant X1
uncharacterized protein LOC107049386 isoform X3
uncharacterized protein LOC107049386 isoform X4
uncharacterized protein LOC107049386 isoform X2
uncharacterized protein LOC107049386 isoform X1
uncharacterized protein LOC107049386 isoform X5
zinc finger protein 229-like, transcript variant X1
zinc finger protein 628, transcript variant X1
zinc finger protein 628, transcript variant X2
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X9
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X10
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X5
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X6
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X1
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X4
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X7
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X3
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X8
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X2
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X12
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X11
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like, transcript variant X13
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X5
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X6
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X1
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X4
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X7
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X3
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X2
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like isoform X9
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like
SH3 domain binding kinase family member 3, transcript variant X2
SH3 domain binding kinase family member 3, transcript variant X1
uncharacterized serine/threonine-protein kinase SBK3-like
deleted in malignant brain tumors 1, transcript variant X1
uncharacterized LOC769729, transcript variant X1
uncharacterized LOC769729, transcript variant X3
uncharacterized LOC769729, transcript variant X2
uncharacterized protein LOC769729 isoform X1
uncharacterized protein LOC769729 isoform X2
uncharacterized protein LOC769729 isoform X3
deleted in malignant brain tumors 1 protein
deleted in malignant brain tumors 1 protein-like, transcript variant X2
deleted in malignant brain tumors 1 protein isoform X2
deleted in malignant brain tumors 1 protein-like, transcript variant X1
deleted in malignant brain tumors 1 protein-like, transcript variant X5
deleted in malignant brain tumors 1 protein-like, transcript variant X4
deleted in malignant brain tumors 1 protein-like, transcript variant X9
deleted in malignant brain tumors 1 protein-like, transcript variant X6
deleted in malignant brain tumors 1 protein-like, transcript variant X8
deleted in malignant brain tumors 1 protein-like, transcript variant X11
deleted in malignant brain tumors 1 protein-like, transcript variant X7
deleted in malignant brain tumors 1 protein-like, transcript variant X10
deleted in malignant brain tumors 1 protein-like, transcript variant X12
deleted in malignant brain tumors 1 protein-like, transcript variant X3
deleted in malignant brain tumors 1 protein isoform X1
deleted in malignant brain tumors 1 protein isoform X5
deleted in malignant brain tumors 1 protein isoform X4
deleted in malignant brain tumors 1 protein isoform X9
deleted in malignant brain tumors 1 protein isoform X6
deleted in malignant brain tumors 1 protein isoform X8
deleted in malignant brain tumors 1 protein isoform X11
deleted in malignant brain tumors 1 protein isoform X7
deleted in malignant brain tumors 1 protein isoform X10
deleted in malignant brain tumors 1 protein isoform X12
deleted in malignant brain tumors 1 protein isoform X3
zinc finger protein 624-like, transcript variant X1
uncharacterized LOC121107831, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sulfotransferase family cytosolic 2B member 1-like, transcript variant X1
sulfotransferase family cytosolic 2B member 1-like, transcript variant X2
deleted in malignant brain tumors 1 protein-like
PIT54 protein; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
sulfotransferase family 2B member 1, transcript variant X1
CD163 molecule like 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC101752152, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 687 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC101752152, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 649 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC101752152, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 647 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC101752152, transcript variant X2
butyrophilin, subfamily 3, member A2, transcript variant X2
butyrophilin, subfamily 3, member A2, transcript variant X1
butyrophilin, subfamily 3, member A2, transcript variant X6
butyrophilin, subfamily 3, member A2, transcript variant X5
butyrophilin, subfamily 3, member A2, transcript variant X3
butyrophilin, subfamily 3, member A2, transcript variant X4
butyrophilin subfamily 2 member A1 isoform X1
butyrophilin subfamily 1 member A1 isoform X5
butyrophilin subfamily 1 member A1 isoform X4
butyrophilin subfamily 1 member A1 isoform X2
butyrophilin subfamily 1 member A1 isoform X3
butyrophilin subfamily 2 member A1-like, transcript variant X1
butyrophilin subfamily 2 member A1-like, transcript variant X6
butyrophilin subfamily 2 member A1-like, transcript variant X2
butyrophilin subfamily 2 member A1-like, transcript variant X4
butyrophilin subfamily 2 member A1-like, transcript variant X3
butyrophilin subfamily 2 member A1-like, transcript variant X5
uncharacterized protein LOC121107837 isoform X1
uncharacterized protein LOC121107837 isoform X6
uncharacterized protein LOC121107837 isoform X2
uncharacterized protein LOC121107837 isoform X4
uncharacterized protein LOC121107837 isoform X3
uncharacterized protein LOC121107837 isoform X5
butyrophilin subfamily 2 member A1-like isoform X2
butyrophilin subfamily 2 member A1-like, transcript variant X14
butyrophilin subfamily 2 member A1-like, transcript variant X15
butyrophilin subfamily 2 member A1-like, transcript variant X11
butyrophilin subfamily 2 member A1-like, transcript variant X18
butyrophilin subfamily 2 member A1-like, transcript variant X17
butyrophilin subfamily 2 member A1-like, transcript variant X16
butyrophilin subfamily 2 member A1-like isoform X11
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X3
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM39-like isoform X1
E3 ubiquitin-protein ligase TRIM39-like isoform X3
E3 ubiquitin-protein ligase TRIM39-like isoform X2
butyrophilin subfamily 3 member A3, transcript variant X1
butyrophilin subfamily 3 member A3, transcript variant X4
butyrophilin subfamily 3 member A3, transcript variant X2
butyrophilin subfamily 3 member A3, transcript variant X6
butyrophilin subfamily 3 member A3, transcript variant X3
butyrophilin subfamily 3 member A3, transcript variant X5
butyrophilin subfamily 3 member A3, transcript variant X7
butyrophilin subfamily 3 member A3, transcript variant X8
butyrophilin subfamily 1 member A1 isoform X6
butyrophilin subfamily 1 member A1 isoform X7
butyrophilin subfamily 1 member A1 isoform X8
butyrophilin subfamily 2 member A1-like, transcript variant X7
butyrophilin subfamily 2 member A1-like, transcript variant X8
butyrophilin subfamily 2 member A1-like, transcript variant X12
butyrophilin subfamily 2 member A1-like, transcript variant X13
butyrophilin subfamily 3 member A1-like isoform X8
butyrophilin subfamily 2 member A1-like isoform X9
butyrophilin subfamily 2 member A1-like isoform X10
butyrophilin subfamily 2 member A1-like, transcript variant X10
butyrophilin subfamily 2 member A1-like, transcript variant X9
butyrophilin subfamily 2 member A1-like isoform X7
uncharacterized LOC124417465, transcript variant X2
uncharacterized LOC124417465, transcript variant X1
butyrophilin subfamily 2 member A1-like isoform X6
butyrophilin subfamily 2 member A1-like isoform X4
butyrophilin subfamily 2 member A1-like isoform X1
E3 ubiquitin-protein ligase TRIM39-like isoform X5
uncharacterized protein LOC107049375 isoform X2
butyrophilin subfamily 1 member A1-like isoform X1
E3 ubiquitin-protein ligase TRIM39-like isoform X4
E3 ubiquitin-protein ligase TRIM39-like isoform X7
E3 ubiquitin-protein ligase TRIM39-like isoform X6
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X4
butyrophilin subfamily 2 member A1-like isoform X5
butyrophilin subfamily 2 member A1-like isoform X3
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X6
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X7
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X5
butyrophilin subfamily 3 member A3-like isoform X5
butyrophilin subfamily 3 member A2-like isoform X2
butyrophilin subfamily 3 member A2-like isoform X3
butyrophilin subfamily 3 member A3-like isoform X6
butyrophilin subfamily 3 member A2-like isoform X1
butyrophilin subfamily 3 member A2-like isoform X4
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X9
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X8
butyrophilin subfamily 3 member A2-like isoform X8
butyrophilin subfamily 3 member A2-like isoform X7
uncharacterized protein LOC112531052 isoform X2
uncharacterized protein LOC112531052 isoform X6
uncharacterized protein LOC112531052 isoform X5
uncharacterized protein LOC112531052 isoform X1
zinc-binding protein A33-like, transcript variant X5
zinc-binding protein A33-like, transcript variant X1
zinc-binding protein A33-like, transcript variant X4
zinc-binding protein A33-like, transcript variant X3
zinc-binding protein A33-like, transcript variant X2
zinc-binding protein A33-like, transcript variant X6
zinc-binding protein A33-like, transcript variant X9
zinc-binding protein A33-like, transcript variant X8
zinc-binding protein A33-like, transcript variant X7
zinc-binding protein A33-like, transcript variant X17
zinc-binding protein A33-like, transcript variant X15
zinc-binding protein A33-like, transcript variant X11
zinc-binding protein A33-like, transcript variant X16
zinc-binding protein A33-like, transcript variant X14
zinc-binding protein A33-like, transcript variant X12
zinc-binding protein A33-like, transcript variant X10
zinc-binding protein A33-like, transcript variant X13
E3 ubiquitin-protein ligase TRIM39-like isoform X17
E3 ubiquitin-protein ligase TRIM39-like isoform X15
E3 ubiquitin-protein ligase TRIM39-like isoform X13
E3 ubiquitin-protein ligase TRIM39-like isoform X11
E3 ubiquitin-protein ligase TRIM39-like isoform X16
E3 ubiquitin-protein ligase TRIM39-like isoform X14
E3 ubiquitin-protein ligase TRIM39-like isoform X12
E3 ubiquitin-protein ligase TRIM39-like isoform X10
E3 ubiquitin-protein ligase TRIM39-like isoform X9
E3 ubiquitin-protein ligase TRIM39-like isoform X8
uncharacterized LOC107055449, transcript variant X2
uncharacterized LOC107055449, transcript variant X1
uncharacterized protein LOC107055449 isoform X2
uncharacterized protein LOC107055449 isoform X1
uncharacterized LOC121107923, transcript variant X1
uncharacterized LOC121107855, transcript variant X2
uncharacterized LOC121107855, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC121107855, transcript variant X1
uncharacterized protein LOC121107855 isoform X1
uncharacterized protein LOC121107855 isoform X3
uncharacterized protein LOC121107855 isoform X2
uncharacterized LOC121107855, transcript variant X4
uncharacterized LOC121107855, transcript variant X5
uncharacterized protein LOC121107855 isoform X4
uncharacterized protein LOC121107855 isoform X5
uncharacterized LOC101750771, transcript variant X2
uncharacterized LOC101750771, transcript variant X1
uncharacterized protein LOC101750771 isoform X2
uncharacterized protein LOC101750771 isoform X1
uncharacterized LOC107055458, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC121107855, transcript variant X6
uncharacterized LOC101750771, transcript variant X7
uncharacterized LOC101750771, transcript variant X6
uncharacterized LOC101750771, transcript variant X5
uncharacterized LOC101750771, transcript variant X4
uncharacterized protein LOC101750771 isoform X7
uncharacterized protein LOC101750771 isoform X6
uncharacterized protein LOC101750771 isoform X5
uncharacterized protein LOC101750771 isoform X4
uncharacterized LOC101750771, transcript variant X3
uncharacterized protein LOC101750771 isoform X3
uncharacterized protein LOC121107847 isoform X1
coiled-coil domain-containing protein 81-like isoform X3
uncharacterized LOC121107896, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC121107896, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
coiled-coil domain-containing protein 81-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
uncharacterized protein LOC121107880 isoform X1
uncharacterized protein LOC124417003 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized protein LOC124417002 isoform X1
uncharacterized protein LOC121107839 isoform X2
uncharacterized protein LOC121106523 isoform X1
uncharacterized protein LOC121106523 isoform X2
uncharacterized protein LOC121106523 isoform X4
uncharacterized protein LOC121106523 isoform X6
coiled-coil domain-containing protein 81-like isoform X5
coiled-coil domain-containing protein 81-like, transcript variant X8
uncharacterized protein LOC107049379 isoform X1
uncharacterized protein LOC107049379 isoform X5
coiled-coil domain-containing protein 81 isoform X2
coiled-coil domain-containing protein 81 isoform X6
coiled-coil domain-containing protein 81 isoform X3
coiled-coil domain-containing protein 81 isoform X4
uncharacterized protein LOC107049387 isoform X1
uncharacterized protein LOC107049387 isoform X2
uncharacterized protein LOC121107836 isoform X1
uncharacterized protein LOC121107836 isoform X2
uncharacterized LOC121107842, transcript variant X4
uncharacterized LOC121107842, transcript variant X5
uncharacterized LOC121107842, transcript variant X1
uncharacterized LOC121107842, transcript variant X3
uncharacterized LOC121107842, transcript variant X2
uncharacterized protein LOC121107842 isoform X1
uncharacterized protein LOC121107842 isoform X2
uncharacterized protein LOC121107842 isoform X3
uncharacterized protein LOC121107842 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 58% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC121107805 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC121107856, transcript variant X3
uncharacterized LOC121107856, transcript variant X1
uncharacterized LOC121107856, transcript variant X2
uncharacterized protein LOC121107856 isoform X1
uncharacterized protein LOC121107856 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized protein LOC121107848 isoform X1
uncharacterized LOC121107904, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC121107904, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC121107904, transcript variant X2
uncharacterized LOC121107904, transcript variant X1
uncharacterized protein LOC121107904 isoform X1
uncharacterized LOC107055452, transcript variant X2
uncharacterized LOC107055452, transcript variant X1
uncharacterized protein LOC107055452 isoform X1
uncharacterized protein LOC107055452 isoform X2
uncharacterized LOC107055460, transcript variant X4
uncharacterized LOC107055460, transcript variant X3
uncharacterized LOC107055460, transcript variant X2
uncharacterized protein LOC107055460 isoform X3
uncharacterized protein LOC107055460 isoform X2
uncharacterized LOC121107857, transcript variant X2
uncharacterized LOC121107857, transcript variant X1
uncharacterized LOC121107857, transcript variant X3
uncharacterized protein LOC121107857 isoform X2
uncharacterized protein LOC121107857 isoform X1
uncharacterized protein LOC121107857 isoform X3
uncharacterized LOC107055460, transcript variant X5
uncharacterized LOC107055460, transcript variant X1
uncharacterized protein LOC107055460 isoform X4
uncharacterized protein LOC107055460 isoform X1
uncharacterized LOC121107858, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC121107858, transcript variant X3
uncharacterized LOC121107858, transcript variant X1
uncharacterized LOC121107915, transcript variant X2
uncharacterized LOC121107915, transcript variant X1
uncharacterized LOC107055447, transcript variant X9
uncharacterized LOC107055447, transcript variant X3
uncharacterized LOC107055447, transcript variant X7
uncharacterized protein LOC107055447 isoform X8
uncharacterized protein LOC107055447 isoform X3
uncharacterized protein LOC107055447 isoform X6
uncharacterized LOC107055447, transcript variant X6
uncharacterized LOC107055447, transcript variant X11
uncharacterized LOC107055447, transcript variant X8
uncharacterized LOC107055447, transcript variant X5
uncharacterized protein LOC107055447 isoform X7
uncharacterized protein LOC107055447 isoform X5
uncharacterized protein LOC107055447 isoform X4
uncharacterized protein LOC107055447 isoform X10
uncharacterized LOC107055447, transcript variant X2
uncharacterized LOC107055447, transcript variant X10
uncharacterized LOC107055447, transcript variant X1
uncharacterized protein LOC107055447 isoform X9
uncharacterized protein LOC107055447 isoform X2
uncharacterized protein LOC107055447 isoform X1
uncharacterized LOC107055447, transcript variant X4
uncharacterized LOC121107873, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC121107873, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC107055456, transcript variant X2
uncharacterized LOC101750718, transcript variant X8
uncharacterized LOC101750718, transcript variant X12
uncharacterized protein LOC101750718 isoform X7
uncharacterized LOC101750718, transcript variant X7
uncharacterized LOC101750718, transcript variant X6
uncharacterized LOC101750718, transcript variant X5
uncharacterized protein LOC101750718 isoform X11
uncharacterized protein LOC101750718 isoform X6
uncharacterized protein LOC101750718 isoform X5
uncharacterized protein LOC101750718 isoform X4
uncharacterized LOC107055456, transcript variant X1
uncharacterized LOC101750718, transcript variant X11
uncharacterized LOC101750718, transcript variant X9
uncharacterized LOC101750718, transcript variant X4
uncharacterized protein LOC101750718 isoform X8
uncharacterized protein LOC101750718 isoform X3
uncharacterized protein LOC101750718 isoform X10
uncharacterized LOC101750718, transcript variant X2
uncharacterized LOC101750718, transcript variant X10
uncharacterized LOC101750718, transcript variant X1
uncharacterized protein LOC101750718 isoform X9
uncharacterized protein LOC101750718 isoform X2
uncharacterized protein LOC101750718 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC101750718, transcript variant X3
uncharacterized LOC112531053, transcript variant X3
uncharacterized protein LOC112531053 isoform X3
uncharacterized LOC112531053, transcript variant X1
uncharacterized protein LOC112531053 isoform X1
uncharacterized LOC107049388, transcript variant X1
uncharacterized LOC107049388, transcript variant X2
uncharacterized protein LOC107049388 isoform X1
uncharacterized protein LOC107049388 isoform X2
uncharacterized LOC121107872, transcript variant X2
uncharacterized LOC121107872, transcript variant X1
uncharacterized protein LOC121107872 isoform X2
uncharacterized protein LOC121107872 isoform X1
uncharacterized LOC124417010, transcript variant X1
uncharacterized protein LOC124417010 isoform X1
uncharacterized LOC112531053, transcript variant X2
uncharacterized protein LOC112531053 isoform X2
uncharacterized LOC107049467, transcript variant X4
uncharacterized LOC107049467, transcript variant X3
uncharacterized LOC107049467, transcript variant X2
uncharacterized LOC107049467, transcript variant X1
uncharacterized protein LOC107049467 isoform X4
uncharacterized protein LOC107049467 isoform X3
uncharacterized protein LOC107049467 isoform X2
uncharacterized protein LOC107049467 isoform X1
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
protein phosphatase 1 regulatory subunit 15A-like
protein phosphatase 1 regulatory subunit 15A isoform X1
uncharacterized LOC427029, transcript variant X6
uncharacterized LOC427029, transcript variant X3
uncharacterized LOC427029, transcript variant X4
uncharacterized LOC427029, transcript variant X2
uncharacterized LOC427029, transcript variant X1
uncharacterized LOC427029, transcript variant X7
uncharacterized LOC427029, transcript variant X5
uncharacterized LOC427029, transcript variant X8
uncharacterized protein LOC427029 isoform X1
uncharacterized protein LOC427029 isoform X2
uncharacterized protein LOC427029 isoform X7
uncharacterized protein LOC427029 isoform X5
uncharacterized protein LOC427029 isoform X8
uncharacterized protein LOC427029 isoform X3
uncharacterized protein LOC427029 isoform X6
uncharacterized protein LOC427029 isoform X4
zinc finger protein 629-like, transcript variant X1
zinc finger protein 629-like, transcript variant X2
zinc finger and SCAN domain-containing protein 12 isoform X1
zinc finger and SCAN domain-containing protein 12 isoform X2
charged multivesicular body protein 2A; Derived by automated computational analysis using gene prediction method: BestRefSeq.
charged multivesicular body protein 2A, transcript variant 2
charged multivesicular body protein 2A, transcript variant 1
charged multivesicular body protein 2A, transcript variant 3
N-acetylmethionine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q5ZHN1.1); acetylation site
propagated from UniProtKB/Swiss-Prot (Q5ZHN1.1); Region: MIT-interacting motif. /evidence=ECO:0000250
tripartite motif containing 28; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
tripartite motif containing 28, transcript variant 4
tripartite motif containing 28, transcript variant 2
tripartite motif containing 28, transcript variant 3
tripartite motif containing 28, transcript variant 1
isoform 4 is encoded by transcript variant 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
transcription intermediary factor 1-beta isoform 4
isoform 2 is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
transcription intermediary factor 1-beta isoform 2
isoform 3 is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
transcription intermediary factor 1-beta isoform 3
isoform 1 is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
transcription intermediary factor 1-beta isoform 1
tripartite motif containing 28, transcript variant X1
transcription intermediary factor 1-beta isoform X1
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X1
zinc finger protein 239-like, transcript variant X3
zinc finger protein 71, transcript variant X1
zinc finger protein 71, transcript variant X2
zinc finger and BTB domain containing 45
zinc finger and BTB domain-containing protein 45
translation initiation factor IF-2-like, transcript variant X6
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like, transcript variant X5
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like, transcript variant X4
translation initiation factor IF-2-like, transcript variant X7
myosin heavy chain, embryonic smooth muscle isoform-like isoform X1
myosin heavy chain, embryonic smooth muscle isoform-like isoform X2
myosin heavy chain, embryonic smooth muscle isoform-like isoform X4
THAP domain containing 8, transcript variant X1
THAP domain containing 8, transcript variant X3
THAP domain containing 8, transcript variant X2
solute carrier family 27 member 2, transcript variant X2
solute carrier family 27 member 2, transcript variant X1
uncharacterized LOC112531204, transcript variant X1
uncharacterized LOC112531204, transcript variant X2
uncharacterized LOC107050008, transcript variant X2
uncharacterized LOC107050008, transcript variant X1
immunoglobulin superfamily member 1-like
leukocyte immunoglobulin-like receptor subfamily B member 4
T-cell-interacting, activating receptor on myeloid cells protein 1-like, transcript variant X3
T-cell-interacting, activating receptor on myeloid cells protein 1-like, transcript variant X2
T-cell-interacting, activating receptor on myeloid cells protein 1-like, transcript variant X1
uncharacterized protein LOC112531128 isoform X2
immunoglobulin superfamily member 1-like isoform X1
uncharacterized protein LOC112531128 isoform X3
T-cell-interacting, activating receptor on myeloid cells protein 1-like
V-set and transmembrane domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: V-set and transmembrane domain-containing protein 1-like
free fatty acid receptor 2-like, transcript variant X1
G-protein coupled receptor 42-like isoform X1
leukocyte immunoglobulin-like receptor subfamily A member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
platelet glycoprotein VI-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
platelet glycoprotein VI-like isoform X1
osteoclast-associated immunoglobulin-like receptor, transcript variant X4
osteoclast-associated immunoglobulin-like receptor, transcript variant X1
osteoclast-associated immunoglobulin-like receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
osteoclast-associated immunoglobulin-like receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
osteoclast-associated immunoglobulin-like receptor isoform X2
osteoclast-associated immunoglobulin-like receptor isoform X3
osteoclast-associated immunoglobulin-like receptor isoform X1
osteoclast-associated immunoglobulin-like receptor isoform X4
osteoclast-associated immunoglobulin-like receptor, transcript variant X5
osteoclast-associated immunoglobulin-like receptor isoform X5
leukocyte immunoglobulin-like receptor subfamily A member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
platelet glycoprotein VI-like, transcript variant X3
platelet glycoprotein VI-like, transcript variant X2
platelet glycoprotein VI-like, transcript variant X4
platelet glycoprotein VI-like, transcript variant X5
platelet glycoprotein VI-like isoform X3
platelet glycoprotein VI-like isoform X2
V-set and transmembrane domain-containing protein 1-like isoform X4
platelet glycoprotein VI-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124417454
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 31 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily A member 2, transcript variant X1
leukocyte immunoglobulin-like receptor subfamily A member 2, transcript variant X2
leukocyte immunoglobulin-like receptor subfamily A member 2, transcript variant X3
immunoglobulin-like receptor CHIR-AB-502, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 mRNAs, 8 long SRA reads, 19 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leukocyte immunoglobulin-like receptor subfamily B member 5 isoform X3
leukocyte immunoglobulin-like receptor subfamily B member 5 isoform X2
immunoglobulin superfamily member 1 isoform X1
leukocyte immunoglobulin-like receptor subfamily B member 5 isoform X4
leukocyte immunoglobulin-like receptor subfamily B member 1, transcript variant X1
leukocyte immunoglobulin-like receptor subfamily B member 1, transcript variant X2
immunoglobulin superfamily member 1-like isoform X2
leukocyte immunoglobulin-like receptor subfamily A member 2, transcript variant X4
leukocyte immunoglobulin-like receptor subfamily A member 2 isoform X4
T-cell-interacting, activating receptor on myeloid cells protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 136 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leukocyte immunoglobulin-like receptor subfamily A member 4 isoform X1
uncharacterized LOC107049014, transcript variant X2
uncharacterized LOC107049014, transcript variant X1
immunoglobulin superfamily member 1 isoform X2
immunoglobulin-like receptor CHIR-AB1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
immunoglobulin-like receptor CHIR-AB1, transcript variant 2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001397444.1
annotated by transcript or proteomic data
The RefSeq transcript has 5 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
immunoglobulin-like receptor CHIR-AB1, transcript variant 1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001146141.3
immunoglobulin-like receptor CHIR-AB1, transcript variant X2
immunoglobulin-like receptor CHIR-AB1, transcript variant X1
immunoglobulin-like receptor CHIR-AB1 isoform 2
isoform 1 precursor is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
immunoglobulin-like receptor CHIR-AB1 isoform 1 precursor
immunoglobulin-like receptor CHIR-AB1 isoform X2
immunoglobulin-like receptor CHIR-AB1 isoform X1
immunoglobulin-like receptor CHIR-A2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001146138.2
The RefSeq transcript has 19 substitutions, 4 frameshifts, 4 non-frameshifting indels and aligns at 92% coverage compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001139610.2
The RefSeq protein has 6 substitutions, 4 frameshifts compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
immunoglobulin-like receptor CHIR-A2 precursor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
immunoglobulin superfamily member 1-like, transcript variant X1
immunoglobulin superfamily member 1-like, transcript variant X2
leukocyte immunoglobulin-like receptor subfamily B member 1 isoform X1
leukocyte immunoglobulin-like receptor subfamily B member 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
osteoclast-associated immunoglobulin-like receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leukocyte immunoglobulin-like receptor subfamily A member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 83 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: osteoclast-associated immunoglobulin-like receptor isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121107843, transcript variant X1
uncharacterized LOC121107843, transcript variant X2
uncharacterized protein LOC121107843 isoform X1
uncharacterized protein LOC121107843 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin superfamily member 1-like, transcript variant X3
immunoglobulin superfamily member 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily A member 2 isoform X1
leukocyte immunoglobulin-like receptor subfamily B member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leukocyte immunoglobulin-like receptor subfamily B member 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
leukocyte immunoglobulin-like receptor subfamily A member 6-like, transcript variant X1
leukocyte immunoglobulin-like receptor subfamily A member 6-like, transcript variant X4
leukocyte immunoglobulin-like receptor subfamily A member 6-like, transcript variant X2
leukocyte immunoglobulin-like receptor subfamily A member 6-like, transcript variant X3
uncharacterized protein LOC100858963 isoform X2
uncharacterized protein LOC100858963 isoform X3
immunoglobulin-like receptor CHIR-B6; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
immunoglobulin-like receptor CHIR-B6, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001318406.3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 32 bases not found in genome assembly
immunoglobulin-like receptor CHIR-B6, transcript variant 1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001398082.1
The RefSeq transcript has 6 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
immunoglobulin-like receptor CHIR-B6 isoform 1 precursor
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 31 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
immunoglobulin-like receptor CHIR-B6 isoform X1
immunoglobulin-like receptor CHIR-B6, transcript variant 2
isoform 2 precursor is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
immunoglobulin-like receptor CHIR-B6 isoform 2 precursor
immunoglobulin-like receptor CHIR-B6 isoform 2
leukocyte immunoglobulin-like receptor subfamily A member 2, transcript variant X6
leukocyte immunoglobulin-like receptor subfamily A member 2, transcript variant X5
leukocyte immunoglobulin-like receptor subfamily A member 2 isoform X3
leukocyte immunoglobulin-like receptor subfamily A member 2 isoform X5
T-cell-interacting, activating receptor on myeloid cells protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 long SRA reads, 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 long SRA reads, 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: free fatty acid receptor 2-like
leukocyte immunoglobulin-like receptor subfamily B member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 142 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
LOW QUALITY PROTEIN: leukocyte immunoglobulin-like receptor subfamily B member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
T-cell-interacting, activating receptor on myeloid cells protein 1-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: free fatty acid receptor 3-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily B member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
T-cell-interacting, activating receptor on myeloid cells protein 1-like, transcript variant X4
V-set and transmembrane domain-containing protein 1-like isoform X2
T-cell-interacting, activating receptor on myeloid cells protein 1-like isoform X3
leukocyte immunoglobulin-like receptor subfamily B member 3 isoform X1
platelet glycoprotein VI-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 7 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: leukocyte immunoglobulin-like receptor subfamily A member 6
free fatty acid receptor 2-like 7; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001318430.1
The RefSeq transcript has 28 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001305359.1
long form; The RefSeq protein has 16 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
platelet glycoprotein VI-like, transcript variant X7
platelet glycoprotein VI-like, transcript variant X8
platelet glycoprotein VI-like, transcript variant X6
platelet glycoprotein VI-like isoform X6
V-set and transmembrane domain-containing protein 1-like, transcript variant X2
V-set and transmembrane domain-containing protein 1-like, transcript variant X1
V-set and transmembrane domain-containing protein 1-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 61% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: immunoglobulin superfamily member 1-like
free fatty acid receptor 2-like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001318994.1
The RefSeq transcript has 17 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
free fatty acid receptor 2-like isoform X1
similar to AA sequence (same species):RefSeq:NP_001305923.1
a-form; short form; The RefSeq protein has 11 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
LOW QUALITY PROTEIN: leukocyte immunoglobulin-like receptor subfamily A member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 146 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily A member 4 isoform X4
V-set and transmembrane domain-containing protein 1 isoform X2
V-set and transmembrane domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
G-protein coupled receptor 42-like 5; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
G-protein coupled receptor 42-like 5, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001318424.1
G-protein coupled receptor 42-like 5 isoform X1
similar to AA sequence (same species):RefSeq:NP_001305353.1
The RefSeq protein has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
T-cell-interacting, activating receptor on myeloid cells protein 1
natural cytotoxicity triggering receptor 1-like, transcript variant X2
natural cytotoxicity triggering receptor 1-like, transcript variant X4
natural cytotoxicity triggering receptor 1-like, transcript variant X1
natural cytotoxicity triggering receptor 1-like, transcript variant X3
T-cell-interacting, activating receptor on myeloid cells protein 1 isoform X4
immunoglobulin-like receptor CHIR-B4; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
immunoglobulin-like receptor CHIR-B4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
immunoglobulin-like receptor CHIR-B4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 long SRA reads, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
immunoglobulin-like receptor CHIR-B4 isoform X1
immunoglobulin-like receptor CHIR-B4 isoform X2
immunoglobulin-like receptor CHIR-B4 precursor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin-like receptor CHIR-AB-600, transcript variant X2
immunoglobulin-like receptor CHIR-AB-600, transcript variant X1
immunoglobulin-like receptor CHIR-AB-600, transcript variant X3
LOW QUALITY PROTEIN: platelet glycoprotein VI isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily B member 1, transcript variant X3
uncharacterized protein LOC107050521 isoform X1
uncharacterized protein LOC107050521 isoform X3
leukocyte immunoglobulin-like receptor subfamily B member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin-like receptor CHIR-B3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 31 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily B member 5-like
leukocyte immunoglobulin-like receptor subfamily B member 3, transcript variant X1
leukocyte immunoglobulin-like receptor subfamily B member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 33 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
free fatty acid receptor 3-like, transcript variant X1
free fatty acid receptor 3-like, transcript variant X2
leucine-rich repeat extensin-like protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
leukocyte immunoglobulin-like receptor subfamily B member 3
leukocyte immunoglobulin-like receptor subfamily A member 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: free fatty acid receptor 3-like
leukocyte immunoglobulin-like receptor subfamily B member 1 isoform X3
leukocyte immunoglobulin-like receptor subfamily B member 1 isoform X4
uncharacterized LOC124417469, transcript variant X1
uncharacterized LOC124417469, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 49 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: platelet glycoprotein VI-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns